Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00063414
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2003-06-25
Brief Title:
ISIS 2302-CS22 A 6-Week Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen ISIS 2302 in Patients With Mild to Moderate Active Ulcerative Colitis
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Organization Data
Organization:
Ionis Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ISIS 2302-CS22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ionis Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None